Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results deaths Eclinical improvement Edeath or ventilation E

COVID 19 hospitalized meta-analysis

RECOVERY colchicine, 2021
 
NCT04381936
RCTcolchicinestandard of careCOVID 19 hospitalizedNA
-/- inconclusive 2%
GRECCO-19, 2020
 
NCT04326790
RCTcolchicinestandard of careCOVID 19 hospitalizedsome concern
55/50 suggested -71%
Lopes MIF, 2020
 
RBR-8jyhxh
RCTcolchicineplaceboCOVID 19 hospitalizedhigh
19/19 inconclusive 5%
Salehzadeh, 2020
 
IRCT20200418047126N1
RCTcolchicineplaceboCOVID 19 hospitalizedsome concern
50/50 inconclusive 0%

COVID 19 outpatients meta-analysis

COLCORONA, 2021
 
NCT04322682
RCTcolchicineplaceboCOVID 19 outpatientslow
2235/2253 safety concern -40%

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).